Miromatrix Medical Inc.
MIRO · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | 31.2% | 6.7% | -99.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | $1 |
| % Margin | -1,018.5% | -1,367.7% | -1,466.2% | 86.6% |
| R&D Expenses | $4 | $4 | $4 | $5 |
| G&A Expenses | $2 | $2 | $3 | $2 |
| SG&A Expenses | $2 | $2 | $3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $3 | $3 | $1 | $1 |
| Operating Expenses | $7 | $7 | $8 | $8 |
| Operating Income | -$7 | -$7 | -$8 | -$7 |
| % Margin | -59,369.1% | -78,530.1% | -101,478.9% | -759% |
| Other Income/Exp. Net | $0 | $0 | $1 | $0 |
| Pre-Tax Income | -$6 | -$7 | -$7 | -$7 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$6 | -$7 | -$7 | -$7 |
| % Margin | -57,746% | -76,675.1% | -90,091.8% | -746.6% |
| EPS | -0.24 | -0.24 | -0.32 | -0.33 |
| % Growth | 0% | 25% | 3% | – |
| EPS Diluted | -0.24 | -0.24 | -0.32 | -0.33 |
| Weighted Avg Shares Out | 27 | 27 | 23 | 21 |
| Weighted Avg Shares Out Dil | 27 | 27 | 23 | 21 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $1 | $0 |
| EBITDA | -$6 | -$6 | -$7 | -$7 |
| % Margin | -55,031.4% | -73,180.8% | -85,713.4% | -745.2% |